Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4
Clinical trial NCT01900704 · COMPLETED
Trial details
- NCT number
- NCT01900704
- Sponsor
- Serenity Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-04-01
- Enrollment
- 810
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.